Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Quazi Mohammad Shahed, CEO of Partex Star Group, discusses with Somoy TV at Complex-1.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Star Group's Chairman, Director is Paul Vermylen
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:00:00
Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck
00:10:00
As China's Linklogis debuts on the Hong Kong stock market, Chairman and CEO Song Qun reveals the supply chain fintech company's future ambitions.
00:10:00
Daniel Dines, CEO and Founder of UiPath, discusses the company's leadership in automation with Dave Vellante at UiPath.
00:10:00
Amex Exploration (TSXV-AMX; OTCQX-AMXEF) has seen a 50%+ move higher in its share price from its Fall, 2023 bottom: a looming resource estimate that will quite possibly establish|VICTOR CANTORE,CEO,Amex Exploration (IE)
00:10:00
NCR Atleos, now an independent company transforming the ATM industry, features CEO Tim Oliver in an interview.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Gold Exploration Funding: Trends, Risks, and Investor Sentiment
00:10:00
Wes Edens on Brightline's Growth and Future Prospects |Wes Edens, Co-Founder, Fortress Investment.
00:10:00
Matthew Lamont, Managing Director of DUG Ltd, leads the company in providing advanced hardware and technology solutions.|Matt Lamont is the co-founder and Managing Director of DUG
00:00:00
AdAlta Phase I Extension Study Results - Tim Oldham, MD, Adalta Ltd
00:10:00
Raising a 50M Fund to Elevate Diverse Founders|Joanna Lee Shevelenko,Founder and General Partner,f7 Ventures
00:10:00
Kingsrose Mining Ltd. diversifies its asset portfolio through the sale of the Way Linggo gold project and progresses exploration efforts, including a significant EM anomaly discovery at the Porsanger project and initiating permitting for drilling at the P
00:10:00
Reaching New Heights in Asset Management: BlackRock & Vanguard Near $20 Trillion Milestone